Clinical Trial Update: Monoclonal Antibody Duration of REsponse in MIgraine After Treatment Interruption

View source ↗

Summary

Clinical trial update indicates ongoing recruitment for a monoclonal antibody targeting migraine to assess duration of response after treatment interruption. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Snippet

Sponsor: Hospital Clínico Universitario de Valladolid | Conditions: Migraine, Headache, Migraine | Status: RECRUITING